Rolf Warta
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat.
Journal: Science translational medicine
Published: March 04, 2026
Spatial distribution and prognostic value of tumor-associated macrophages in head and neck squamous cell carcinomas.
Journal: Frontiers in oncology
Published: February 07, 2026
Profiling of rare immune cell populations and integrative analysis identify immune ecotypes in newly diagnosed meningiomas.
Journal: Acta neuropathologica communications
Published: December 23, 2025
An Above-Average Lymph Node Yield Removed During Curative Neck Dissection in Advanced Head and Neck Squamous Cell Carcinomas Improves Survival.
Journal: Cancers
Published: November 23, 2025
Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors.
Journal: NPJ precision oncology
Published: August 20, 2025
Cisplatin resistance in head and neck squamous cell carcinoma is linked to DNA damage response and cell cycle arrest transcriptomics rather than poor drug uptake.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: May 23, 2025
Kynurenine enhances aryl hydrocarbon receptor signaling and expression levels of multidrug resistance genes in head and neck squamous cell carcinoma cell lines but does not change the potency of antineoplastic drugs.
Journal: Toxicology and applied pharmacology
Published: April 07, 2025
The Molecular and Immunological Landscape of Meningiomas.
Journal: International journal of molecular sciences
Published: July 16, 2024
Last Updated: 09/26/2026